Back to search results

Exploring Mindsets, Beliefs and Resilience Across the Cancer Experience

This study is exploring how digital programs can help newly diagnosed cancer patients with their overall health and well-being. You might be able to join if you are 18 or older, have a recent diagnosis of non-metastatic (stage I-III) or blood cancer, and are currently receiving or planning to receive systemic treatment (like chemotherapy or immunotherapy). The study is testing two digital programs: MINDSET, which uses films and activities, and a Digital Information Series for Cancer, which offers videos and questions on coping. Researchers will measure success by looking at your quality of life using a tool called the Functional Assessment of Cancer Therapy - General (FACT-G). The current status of this study is unclear.

Study design
This interventional study plans to enroll 440 participants who will be randomly assigned to one of two digital programs.
What's involved
You will complete questionnaires, access digital courses, and provide blood samples using at-home collection kits that are mailed to you. These activities will take place at various times during treatment and for up to 6 months after.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 and 6 months after their treatment phase.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06705218

Exploring Mindsets, Beliefs and Resilience Across the Cancer Experience

Active, Not Recruiting
NAAges 18+InterventionalSupportive care
Stanford University
~440 participants
Updated 2026-08-26 on ClinicalTrials.gov
What's tested:MINDSETDigital Information Series for Cancer

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Functional Assessment of Cancer Therapy - General (FACT-G)
Measured over Treatment Phase: Weeks 0 (Baseline), 2, 4, 6, 10 Follow Up: Months 3, 6

Conditions

Cancer

Explore related trials

Hematologic NeoplasmSolid Neoplasm

NCT06705218

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Stanford University

    Palo Alto, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Alia J Crum, PhD · PRINCIPAL_INVESTIGATOR · Stanford University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Initial (non-recurrent) diagnosis of non-metastatic (stage I-III) or hematological malignancy.
Diagnosis in the past 150 days.
Currently receiving active systemic treatment or with a planned systemic treatment (including chemotherapy, immunotherapy or other targeted therapies).
Eighteen years of age or older.
Fluent in English.
Currently reside in the United States.
Access to a computer, tablet, or smartphone (a mobile phone that performs many of the functions of a computer, typically including a touchscreen interface, internet access, and an operating system capable of running downloaded applications, or tablet that runs iOS or Android software, with cellular data service or wifi access).
Currently receiving treatment for severe depression, severe anxiety, bipolar disorder, post-traumatic stress disorder, or schizophrenia.

What this trial measures

  • Functional Assessment of Cancer Therapy - General (FACT-G)Treatment Phase: Weeks 0 (Baseline), 2, 4, 6, 10 Follow Up: Months 3, 6

    Physical, emotional, social and functional quality of life will be assessed using the FACT-G questionnaire. The Functional Assessment of Cancer Therapy - General (FACT-G) is a 27-item questionnaire designed to measure four domains of quality of life in cancer patients: Physical, social, emotional, and functional well being. Original development and validation involved 854 patients with cancer and 15 oncology specialists.